Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma-Reference-Cited by-同舟云学术

Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma

Published:2019-12-13 Issue:12 Volume:14 Page:e0225998
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Choi Young Bae^ORCID,Son Meong Hi,Cho Hee Won,Ma Youngeun,Lee Ji Won,Kang Eun-Suk,Yoo Keon Hee,Her Jung Hyun,Lim Okjae,Jung Miyoung,Hwang Yu Kyeong,Sung Ki Woong,Koo Hong Hoe

Funder

SMC Research and Development Grant

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update;RE George;J Clin Oncol,2006

2. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study;KK Matthay;J Clin Oncol,2009

3. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study;KW Sung;Bone Marrow Transplant,2013

4. Graft-versus-tumour effect in refractory metastatic neuroblastoma;A Marabelle;Bone Marrow Transplant,2007

5. Reduced-intensity allogeneic stem cell transplantation for children with neuroblastoma who failed tandem autologous stem cell transplantation;KW Sung;Pediatr Blood Cancer,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation;Scientific Reports;2024-09-09

2. Acute toxicities of intravenous, intraperitoneal, or intratumoral injection of natural killer cells in human pancreatic adenocarcinoma-bearing mice: Randomized study;International Immunopharmacology;2023-11

3. Immunotherapy for neuroblastoma by hematopoietic cell transplantation and post-transplant immunomodulation;Critical Reviews in Oncology/Hematology;2023-05

4. Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants;Cancers;2022-09-20

5. The EHA Research Roadmap: Hematopoietic Stem Cells and Allotransplantation;HemaSphere;2022-04-29